Aerovate Therapeutics Inc (AVTE)
21.75
+0.18
(+0.83%)
USD |
NASDAQ |
Apr 26, 16:00
21.82
+0.07
(+0.32%)
After-Hours: 20:00
Aerovate Therapeutics Price to Book Value: 5.537 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 5.537 |
| April 25, 2024 | 5.491 |
| April 24, 2024 | 5.397 |
| April 23, 2024 | 5.911 |
| April 22, 2024 | 5.644 |
| April 19, 2024 | 5.613 |
| April 18, 2024 | 5.498 |
| April 17, 2024 | 5.728 |
| April 16, 2024 | 6.013 |
| April 15, 2024 | 6.440 |
| April 12, 2024 | 6.425 |
| April 11, 2024 | 6.845 |
| April 10, 2024 | 6.876 |
| April 09, 2024 | 7.140 |
| April 08, 2024 | 6.741 |
| April 05, 2024 | 6.377 |
| April 04, 2024 | 7.408 |
| April 03, 2024 | 7.413 |
| April 02, 2024 | 7.530 |
| April 01, 2024 | 7.828 |
| March 28, 2024 | 7.527 |
| March 27, 2024 | 7.255 |
| March 26, 2024 | 6.529 |
| March 25, 2024 | 6.860 |
| March 22, 2024 | 6.562 |
| Date | Value |
|---|---|
| March 21, 2024 | 6.618 |
| March 20, 2024 | 6.567 |
| March 19, 2024 | 6.524 |
| March 18, 2024 | 6.694 |
| March 15, 2024 | 6.772 |
| March 14, 2024 | 6.161 |
| March 13, 2024 | 6.843 |
| March 12, 2024 | 6.123 |
| March 11, 2024 | 6.283 |
| March 08, 2024 | 6.727 |
| March 07, 2024 | 6.189 |
| March 06, 2024 | 6.054 |
| March 05, 2024 | 5.793 |
| March 04, 2024 | 5.704 |
| March 01, 2024 | 6.044 |
| February 29, 2024 | 5.854 |
| February 28, 2024 | 5.857 |
| February 27, 2024 | 6.029 |
| February 26, 2024 | 5.260 |
| February 23, 2024 | 4.979 |
| February 22, 2024 | 4.774 |
| February 21, 2024 | 4.781 |
| February 20, 2024 | 4.768 |
| February 16, 2024 | 5.304 |
| February 15, 2024 | 5.489 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.168
Minimum
Jan 21 2022
7.828
Maximum
Apr 01 2024
3.366
Average
3.191
Median
Nov 21 2023
Price to Book Value Benchmarks
| Insmed Inc | -- |
| Annexon Inc | 1.689 |
| CEL-SCI Corp | 6.144 |
| AIM ImmunoTech Inc | 2.239 |
| IGC Pharma Inc | 3.224 |
Price to Book Value Related Metrics
| Price | 21.75 |
| Earnings Yield | -13.24% |
| Market Cap | 606.02M |